KIT and cancer: Recently, for the first time, we estimated the c-Myc expression in peripheral blood NK cells from patients with cancer: c-Myc mRNA expression, as well as expression of another proto-oncogene c-kit, was significantly decreased in NK cells in all tested cancer patients independently of tumor location, stage of disease or presence of metastases [7].